Mai Onishi, Shigeo Yamaguchi, Xuan Wen, Min Han, Hidenori Kido, Tomoyuki Aruga, Shin-Ichiro Horiguchi, Shunsuke Kato. TP53 Signature Score Predicts Prognosis and Immune Response in Triple-negative Breast Cancer. Anticancer research. 2023. 43. 4. 1731-1739
Hidenori Kido, Shimada Naoko, Serizawa Nobuko, Gyouda Yu, Takasaki Yusuke, Fujino Kazunari, Nasu Motomi, Suzuki Mario, Shinichi Ooba, Sai Hyonmi, et al. Current status and issues of cancer genome profiling tests for insurance at our hospital. ANNALS OF ONCOLOGY. 2022. 33. S513-S514
Min Han, Shigeo Yamaguchi, Mai Onishi, Tomoaki Fujii, Masaki Hosoya, Xuan Wen, Hidenori Kido, Shunsuke Kato. The MDM2 and CDKN2A Copy-number-variation Influence the TP53-signature-score in Wild-type TP53 Luminal Type Breast Cancer. Anticancer research. 2022. 42. 5. 2277-2288
Hidenori Kido, Shunsuke Kato, Kimihiko Funahashi, Kazutoshi Shibuya, Yousuke Sasaki, Yoshihisa Urita, Masaaki Hori, Sunao Mizumura. The metabolic parameters based on volume in PET/CT are associated with clinicopathological N stage of colorectal cancer and can predict prognosis. EJNMMI research. 2021. 11. 1. 87-87